ANTARES PHARMA, INC. (NASDAQ:ATRS) Files An 8-K Financial Statements and Exhibits

57

ANTARES PHARMA, INC. (NASDAQ:ATRS) Files An 8-K Financial Statements and Exhibits
Item 9.01

Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Index


ANTARES PHARMA, INC. Exhibit
EX-99.1 2 atrs-ex991_6.htm EX-99.1 PRESS RELEASE DATED OCTOBER 12,…
To view the full exhibit click here

About ANTARES PHARMA, INC. (NASDAQ:ATRS)

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. Its subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injectors, Vision reusable needle-free injectors and disposable multi-use pen injectors. The Company makes a reusable, needle-free spring action injection device, ZOMA-Jet or Twin-Jector, which is marketed through its partners for use with human growth hormone (hGH). The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies. The Company has developed OTREXUP (methotrexate) injection, which is a single dose, disposable auto injector.

An ad to help with our costs